Empagliflozin led to promising weight loss outcomes in patients with prediabetes and diabetes, with the results being more prominent in men than in women.

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

GLP-1 drugs work by mimicking the hormone GLP-1, resulting in weight loss, lowering hemoglobin A1c (HbA1c ... VK2735 has demonstrated superior weight reduction capabilities in both clinical ...

Maintaining a stable normal blood sugar range is crucial for various health reasons. It can help manage weight gain/loss by providing energy to cells efficiently and regulate your mood by maintaining ...

Nearly half of U.S. adults say starting a new diet is one of their New Year's resolutions, according to a new Physicians Committee for Responsible Medicine/Morning Consult survey.

an average weight loss of 5% for patients with >30 BMI and a 1 percentage point reduction in hemoglobin A1c. Wisp launches weight care vertical with GLP-1s, OTC supplement “Personalized ...

Treatment for T2D typically begins with oral antidiabetic agents and a reduction in glycated haemoglobin ... with modest progressive weight loss and a lower incidence of hypoglycaemia.

In the 2021 review, the authors noted that some studies had found that lower glucose levels and 3-month average A1C results helped ... indicate there may be weight loss potential.

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight loss solution – an average 15% weight reduction, according to clinical ...